Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
27.15
+0.45 (1.69%)
Jan 16, 2026, 4:00 PM EST - Market closed
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $1.68 billion as of January 16, 2026. Its market cap has increased by 222.08% in one year.
Market Cap
1.68B
Enterprise Value
1.67B
1-Year Change
222.08%
Ranking
Category
Stock Price
$27.15
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $1.68B, an increase of 370.46%. That is a compound annual growth rate of 23.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.68B | -2.90% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |